Diabetes influences liver stiffness in chronic hepatitis C patients with and without virological cure: A longitudinal study

Detalhes bibliográficos
Autor(a) principal: Pontual, Daniela Malta
Data de Publicação: 2021
Outros Autores: Nabuco, Leticia Cancella, Luiz, Ronir Raggio, Cardoso, Ana Carolina, Perez, Renata M., Villela-Nogueira, Cristiane A.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinics
Texto Completo: https://www.revistas.usp.br/clinics/article/view/212872
Resumo: OBJECTIVES: The aim was to prospectively assess the variation in liver stiffness (LS) and the associated factors for LS progression in a cohort of naïve, non-responder (NR), and sustained virological response (SVR) chronic hepatitis C (CHC) patients. METHODS: This was a longitudinal study on CHC patients prospectively followed with serial elastography (Fibroscan®). The LS progression rate was determined, and the associated factors for progression were assessed using multiple linear regression analysis. RESULTS: A total of 406 patients were followed up for 44 (35-53) months [naïve (29%), NR (24%), and SVR (47%)]. At the end of the follow-up period, the SVR group had a significant decrease in LS [11.8 (9.2) vs. 8.8 (8.4) kPa (p<0.001)], the NR group had a significant increase in LS [6.6 (5.2) vs. 7.1 (4.5) kPa (p=0.069)], and the naïve group had no change in LS [6.3 (3.0) vs. 6.0 (3.8) kPa (p=0.22)]. The related factors for LS progression were lack of SVR (p=0.002) and diabetes (p=0.05). In the non-diabetic SVR group, a negative rate of progression (-0.047 kPa/month) was observed, whereas in the diabetic SVR group, a positive rate of progression (+0.037 kPa/month) was observed. The highest rate of progression was observed in NR with diabetes at the rate of +0.044 kPa/month. CONCLUSION: LS in diabetes patients progresses despite SVR, suggesting the need for a close follow-up of this group post-treatment considering the risk of progression of liver disease even after SVR.
id USP-19_1765f90d1a4792d7a7e370f6f883c327
oai_identifier_str oai:revistas.usp.br:article/212872
network_acronym_str USP-19
network_name_str Clinics
repository_id_str
spelling Diabetes influences liver stiffness in chronic hepatitis C patients with and without virological cure: A longitudinal studyChronic Hepatitis CElastographySustained Virological ResponseDiabetes MellitusOBJECTIVES: The aim was to prospectively assess the variation in liver stiffness (LS) and the associated factors for LS progression in a cohort of naïve, non-responder (NR), and sustained virological response (SVR) chronic hepatitis C (CHC) patients. METHODS: This was a longitudinal study on CHC patients prospectively followed with serial elastography (Fibroscan®). The LS progression rate was determined, and the associated factors for progression were assessed using multiple linear regression analysis. RESULTS: A total of 406 patients were followed up for 44 (35-53) months [naïve (29%), NR (24%), and SVR (47%)]. At the end of the follow-up period, the SVR group had a significant decrease in LS [11.8 (9.2) vs. 8.8 (8.4) kPa (p<0.001)], the NR group had a significant increase in LS [6.6 (5.2) vs. 7.1 (4.5) kPa (p=0.069)], and the naïve group had no change in LS [6.3 (3.0) vs. 6.0 (3.8) kPa (p=0.22)]. The related factors for LS progression were lack of SVR (p=0.002) and diabetes (p=0.05). In the non-diabetic SVR group, a negative rate of progression (-0.047 kPa/month) was observed, whereas in the diabetic SVR group, a positive rate of progression (+0.037 kPa/month) was observed. The highest rate of progression was observed in NR with diabetes at the rate of +0.044 kPa/month. CONCLUSION: LS in diabetes patients progresses despite SVR, suggesting the need for a close follow-up of this group post-treatment considering the risk of progression of liver disease even after SVR.Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2021-11-08info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/21287210.6061/clinics/2021/e3236Clinics; Vol. 76 (2021); e3236Clinics; v. 76 (2021); e3236Clinics; Vol. 76 (2021); e32361980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/212872/194896Copyright (c) 2023 Clinicsinfo:eu-repo/semantics/openAccessPontual, Daniela MaltaNabuco, Leticia CancellaLuiz, Ronir RaggioCardoso, Ana CarolinaPerez, Renata M.Villela-Nogueira, Cristiane A.2023-07-06T13:04:05Zoai:revistas.usp.br:article/212872Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2023-07-06T13:04:05Clinics - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Diabetes influences liver stiffness in chronic hepatitis C patients with and without virological cure: A longitudinal study
title Diabetes influences liver stiffness in chronic hepatitis C patients with and without virological cure: A longitudinal study
spellingShingle Diabetes influences liver stiffness in chronic hepatitis C patients with and without virological cure: A longitudinal study
Pontual, Daniela Malta
Chronic Hepatitis C
Elastography
Sustained Virological Response
Diabetes Mellitus
title_short Diabetes influences liver stiffness in chronic hepatitis C patients with and without virological cure: A longitudinal study
title_full Diabetes influences liver stiffness in chronic hepatitis C patients with and without virological cure: A longitudinal study
title_fullStr Diabetes influences liver stiffness in chronic hepatitis C patients with and without virological cure: A longitudinal study
title_full_unstemmed Diabetes influences liver stiffness in chronic hepatitis C patients with and without virological cure: A longitudinal study
title_sort Diabetes influences liver stiffness in chronic hepatitis C patients with and without virological cure: A longitudinal study
author Pontual, Daniela Malta
author_facet Pontual, Daniela Malta
Nabuco, Leticia Cancella
Luiz, Ronir Raggio
Cardoso, Ana Carolina
Perez, Renata M.
Villela-Nogueira, Cristiane A.
author_role author
author2 Nabuco, Leticia Cancella
Luiz, Ronir Raggio
Cardoso, Ana Carolina
Perez, Renata M.
Villela-Nogueira, Cristiane A.
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Pontual, Daniela Malta
Nabuco, Leticia Cancella
Luiz, Ronir Raggio
Cardoso, Ana Carolina
Perez, Renata M.
Villela-Nogueira, Cristiane A.
dc.subject.por.fl_str_mv Chronic Hepatitis C
Elastography
Sustained Virological Response
Diabetes Mellitus
topic Chronic Hepatitis C
Elastography
Sustained Virological Response
Diabetes Mellitus
description OBJECTIVES: The aim was to prospectively assess the variation in liver stiffness (LS) and the associated factors for LS progression in a cohort of naïve, non-responder (NR), and sustained virological response (SVR) chronic hepatitis C (CHC) patients. METHODS: This was a longitudinal study on CHC patients prospectively followed with serial elastography (Fibroscan®). The LS progression rate was determined, and the associated factors for progression were assessed using multiple linear regression analysis. RESULTS: A total of 406 patients were followed up for 44 (35-53) months [naïve (29%), NR (24%), and SVR (47%)]. At the end of the follow-up period, the SVR group had a significant decrease in LS [11.8 (9.2) vs. 8.8 (8.4) kPa (p<0.001)], the NR group had a significant increase in LS [6.6 (5.2) vs. 7.1 (4.5) kPa (p=0.069)], and the naïve group had no change in LS [6.3 (3.0) vs. 6.0 (3.8) kPa (p=0.22)]. The related factors for LS progression were lack of SVR (p=0.002) and diabetes (p=0.05). In the non-diabetic SVR group, a negative rate of progression (-0.047 kPa/month) was observed, whereas in the diabetic SVR group, a positive rate of progression (+0.037 kPa/month) was observed. The highest rate of progression was observed in NR with diabetes at the rate of +0.044 kPa/month. CONCLUSION: LS in diabetes patients progresses despite SVR, suggesting the need for a close follow-up of this group post-treatment considering the risk of progression of liver disease even after SVR.
publishDate 2021
dc.date.none.fl_str_mv 2021-11-08
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/clinics/article/view/212872
10.6061/clinics/2021/e3236
url https://www.revistas.usp.br/clinics/article/view/212872
identifier_str_mv 10.6061/clinics/2021/e3236
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/clinics/article/view/212872/194896
dc.rights.driver.fl_str_mv Copyright (c) 2023 Clinics
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2023 Clinics
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
dc.source.none.fl_str_mv Clinics; Vol. 76 (2021); e3236
Clinics; v. 76 (2021); e3236
Clinics; Vol. 76 (2021); e3236
1980-5322
1807-5932
reponame:Clinics
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Clinics
collection Clinics
repository.name.fl_str_mv Clinics - Universidade de São Paulo (USP)
repository.mail.fl_str_mv ||clinics@hc.fm.usp.br
_version_ 1800222766104838144